Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.886,29
1,59%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ RAPT Therapeutics Inc (RAPT) RAPT Therapeutics Inc (RAPT) Notizie

RAPT Therapeutics Inc

RAPT
8,30
0,175 (2,15%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/4/202418:00GLOBERAPT Therapeutics Announces Promising Results from Phase 2..
07/3/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202414:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202414:03EDGAR2Form 8-K - Current report
07/3/202414:00GLOBERAPT Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202422:30GLOBERAPT Therapeutics Announces Multiple Late-Breaking..
22/2/202423:13EDGAR2Form 8-K - Current report
20/2/202422:29EDGAR2Form 8-K - Current report
20/2/202413:30GLOBERAPT Therapeutics Announces Clinical Hold on Studies..
14/2/202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:00GLOBERAPT Therapeutics Bolsters Leadership Team with the..
31/1/202414:00GLOBERAPT Therapeutics to Participate in the Guggenheim..
02/1/202414:00GLOBERAPT Therapeutics to Present at the 42nd Annual J.P. Morgan..
27/11/202314:00GLOBERAPT Therapeutics Announces Publication of Phase 1a/1b..
13/11/202314:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:03EDGAR2Form 8-K - Current report
13/11/202314:00GLOBERAPT Therapeutics Reports Third Quarter 2023 Financial..
03/11/202317:03EDGAR2Form 8-K - Current report
03/11/202317:00GLOBERAPT Therapeutics Announces Positive Data, Including..
01/11/202321:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18/10/202315:00GLOBERAPT Therapeutics Announces Two FLX475 Presentations at the..
30/8/202322:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11/8/202322:02EDGAR2Form 8-K - Current report
11/8/202314:57EDGAR2Form S-3 - Registration statement under Securities Act of..
11/8/202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202314:05EDGAR2Form 8-K - Current report
11/8/202314:00GLOBERAPT Therapeutics Reports Second Quarter 2023 Financial..
07/6/202314:00GLOBERAPT Therapeutics to Participate in the Goldman Sachs Global..
25/5/202323:00GLOBERAPT Therapeutics to Present Biomarker Data Corroborating..
11/5/202314:00GLOBERAPT Therapeutics Reports First Quarter 2023 Financial..
Apertura: 8,28 Min: 8,15 Max: 8,58
Chiusura: 8,125

La tua Cronologia

NASDAQ
RAPT
RAPT Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network